The Sonic hedgehog (SHH)-signalling pathway mediates epithelial-mesenchymal interactions in several tissues during development and disease, and we have investigated its role in rat ventral prostate (VP) development. We have demonstrated that Shh and Ptc expression correlates with growth and development of the prostate and that their expression is not regulated by androgens in the VP. Prostatic budding was induced in response to testosterone in Shh null mouse urogenital sinus (UGS) explants grown in vitro and in rat UGS explants cultured with cyclopamine, suggesting that SHH-signalling is not critical for prostatic induction. SHH-signalling was disrupted at later stages of VP development (in vitro), resulting in a reduction in organ size, an increase in ductal tip number, and reduced proliferation of ductal tip epithelia. The addition of recombinant SHH to VPs grown in vitro caused a decrease in ductal tip number and expansion of the mesenchyme. In the presence of testosterone, inhibition of SHH-signalling accelerated the canalisation of prostatic epithelial ducts and resulted in ducts that showed morphological similarities to cribiform prostatic intraepithelial neoplasia (PIN). The epithelia of these ducts also demonstrated precocious and aberrant differentiation, when examined by immunohistochemistry for p63 and cytokeratin 14. In conclusion, we show that SHH-signalling is not essential for prostatic induction, but is important for prostatic growth, branching, and proliferation, and that androgen-stimulated growth in the absence of signalling from the SHH pathway results in aberrant epithelial differentiation.
Introduction
The Sonic hedgehog (SHH)-signalling pathway regulates epithelial-mesenchymal interactions during the development of many organs. SHH is synthesised in epithelial cells, and in many situations, acts as a paracrine factor through its receptor Patched1 (PTC) that is expressed in adjacent mesenchymal cells. Shh null mice exhibit various developmental defects, including cyclopia, neural tube defects, and absence of distal limb structures (Chiang et al., 1996) . Inhibition of SHH-signalling using cyclopamine (Cy) has demonstrated its role in development of the neural tube (Incardona et al., 1998) , gastrointestinal tract (Sukegawa et al., 2000) , pancreas (Kim and Melton, 1998) , and in hair follicle morphogenesis (Chiang et al., 1999) . SHH-signalling is also required for branching morphogenesis of the lung (Bellusci et al., 1997; Pepicelli et al., 1998) . Shh transcript expression has been reported in the urogenital sinus (UGS) epithelium (Bitgood and McMahon, 1995) , where it is required for the formation of external genitalia (Haraguchi et al., 2001; Perriton et al., 2002) , and has recently been implicated in prostate development (Lamm et al., 2002; Podlasek et al., 1999) .
Reciprocal mesenchymal-epithelial interactions play a key role in directing growth of the prostate during development and disease Marker et al., 2003) . Under normal developmental conditions epithelial growth is controlled through androgen-regulated signalling in the mesenchyme (Cunha and Chung, 1981; Gao et al., 2001) .
Conversely, paracrine signalling from the epithelium patterns stromal differentiation during prostate development and maintains the mesenchyme/stroma in the adult prostate . Little is known about the pathways that regulate mesenchymal-epithelial interactions in prostatic growth; however, a role for the SHH-signalling pathway has been established. The importance of SHH-signalling in prostatic growth was first demonstrated by antibody blockade of SHH, which abrogated growth of the prostate from male UGS tissue transplanted into male host mice (Podlasek et al., 1999) . Podlasek et al. also reported that Shh transcript expression was upregulated in the male UGS in response to androgens, concluding that androgen-induced expression of Shh in the UGS is necessary for prostatic induction. More recently, Lamm et al. (2002) demonstrated that inhibition of SHH-signalling in mouse UGS explants, cultured using both anti-SHH antibody and cyclopamine, reduced ductal budding concurrent with reduced expression of Gli1, a transcriptional mediator of SHH-signalling. This work also suggested that androgens induce a male-specific pattern of Shh expression. However, our data on SHH-signalling in prostate development do not concur with some aspects of these studies. We have addressed the role of SHH-signalling in prostate organogenesis, by detailed analysis of Shh and Ptc transcript expression and regulation. We have grown Shh null mouse UGS explants in vitro, disrupted the SHHsignalling pathway in rat UGS explants, and inhibited and supplemented the SHH-signalling pathway in rat VPs. Our results suggest that Shh and Ptc transcript expression is not dependent on androgens and, while not required for prostatic induction, SHH-signalling is important in later stages of prostate development. Furthermore, we have demonstrated that inhibition of SHH-signalling during VP growth affects epithelial growth, patterning, and differentiation, and results in prostatic epithelial ducts showing morphological appearances similar to human cribiform prostatic intraepithelial neoplasia (PIN).
Materials and methods

Tissue isolation
Whole urogenital tracts (UGTs), VPs, and urethras (URs) were microdissected from either outbred Wistar rats or Shh null mice or littermates, on an outbred CD1 background (Chiang et al., 1996) , where the day of copulatory plug observation was taken as e0.5, and day of birth was designated P0.
RNase protection assays
Total RNA was prepared as described (Chomczynski and Sacchi, 1987) . DNA templates for Shh and Ptc riboprobes were synthesised by RT-PCR from P0 UGT cDNA and subcloned into pBluescript KSIIϩ (Stratagene, USA). PCR primers were designed by using GenBank-published cDNA sequences (Shh: GenBank Accession No. NM_017221; Primers: L-ACCGCAGCAAGTATGGCA, R-TCCAG-GAAGGTGAGGAAG; Ptc: GenBank Accession No. AF079162; Primers L-GCATTGGCAGGAGGAGTTGAT-TGTG, R-CCACTCGGATGACACTGACA). DNA templates for Cyclophilin (Cphn) and 28S riboprobes were from Ambion, Inc., USA. 32 P-labelled anti-sense riboprobes were transcribed, and RNase protection assays performed as previously described in detail (Thomson and Cunha, 1999) . RNase protected products from Shh, Ptc, Cphn, and 28S riboprobes were 269, 322, 103, and 155 nt, respectively. Gels were imaged by using a Storm PhosphorImager (Molecular Dynamics, USA), and transcript abundance was determined from the intensities of bands, calculated using ImageQuant V.1.2 (Molecular Dynamics, USA). Transcript abundances were normalised to either Cphn or 28S internal standards (28S was used as an internal standard in postnatal samples as Cphn expression was found to decrease with age).
In situ hybridisation
In situ hybridisation was performed on 7-m paraffinembedded sections by using a procedure slightly modified from previously described protocols (Frohman et al., 1990; Thomson and Cunha, 1999) . 33 P-labelled anti-sense and control sense riboprobes were synthesised by using the same Shh DNA template and method as for RNase protection assays. Slides were dipped in G.5 emulsion (Ilford, UK) and developed according to manufacturer's instructions. Dark field images were inverted, their grains coloured red, and overlayed with bright field images using Adobe Photoshop software.
Organ culture
Serum-free organ culture was performed as previously described (Thomson and Cunha, 1999) . Culture media was supplemented with 10 Ϫ8 M testosterone and/or either 1, 5, or 10 M cyclopamine (kindly provided by W. Gaffield), or 100 g ml Ϫ1 anti-SHH antibody (clone 5E1, Developmental Studies Hybridoma Bank, University of Iowa), or 0.2 g ml Ϫ1 recombinant SHH protein (Research Diagnostics, USA). NIH Image software was used to trace around the perimeter of images of VPs grown in vitro, giving a measurement of organ perimeter in pixels. The two-dimensional area of organs was calculated by using NIH Image software, by quantifying the number of square pixels contained within the measured organ perimeter.
Histology
The histology of sections was examined either by trichrome or haematoxylin staining. For CK14 and p63 immunostaining, with diamino benzamide (DAB) detection, sections were pressure-cooked in 10 mM citric acid, pH 6.0, for 2 min before following a previously published protocol (Thomson et al., 2002) . Anti-CK14 antibody (a gift from B. Lane) was diluted 1:100, and anti-p63 antibody (Santa Cruz Biotechnologies Inc., USA) was diluted 1:500. BrdU and pan-cytokeratin colocalisation immunohistochemistry was performed as previously described (Thomson et al., 2002) , using 1:300 dilution of anti-BrdU antibody (Fitzgerald Industries International Inc., USA) and 1:200 dilution of antipan-cytokeratin antibody (Sigma, UK). BrdU was detected with Alexofluor 488 (Molecular Probes Inc., USA) and pan-cytokeratin was detected with Cy5 (Amersham Biosciences, UK). Proliferative indices were calculated by counting the number of pan-cytokeratin-positive epithelial cells or pan-cytokeratin-negative mesenchymal cells that were also BrdU-positive.
Results
Shh mRNA expression in the male UGT
Shh transcripts were localised to the urethral epithelium (URE), and epithelia of the developing ventral prostate (VPE), dorsal prostate (DPE), and dorsolateral prostate (DLPE) of P0 male UGTs by in situ hybridisation ( Fig. 1A  and B ). Signal intensities appeared similar along the length of prostatic buds and between prostatic buds and URE. Shh transcripts were not observed in the stroma of the UGT. No signal was observed by using a control sense riboprobe (data not shown).
Shh and Ptc mRNA levels were also examined by RNase protection assay (RPA). Shh and Ptc mRNAs were most abundant at e18.5 in the UGT (Fig. 1C ). Transcript levels were low between e19.5 and e21.5, but were elevated at P0. Shh and Ptc mRNA expression was higher in the VP than the UGT at P0, which may have been due to variation in the proportions of epithelium in these tissues. In the postnatal VP, Shh and Ptc transcript levels decreased with increasing age (Fig. 1D ). Shh and Ptc mRNAs were most abundant at P0 and P2, but by P6 these levels were four-fold lower than at P0. Shh and Ptc mRNAs were almost undetectable at P20 and absent in adults. A comparison of Shh and Ptc transcript levels in postnatal VPs and URs (urethras) showed transcripts to be more abundant in VPs than URs until P2, but by P4 this situation was reversed ( Fig. 1E ). Unlike the VP, expression in the UR was maintained beyond P20, separating the developmental pathways of these structures.
Shh mRNA expression is not androgen-regulated in the VP
As prostate development occurs only in males, and malespecific upregulation of Shh mRNA in the mouse UGS had been reported (Podlasek et al., 1999) , Shh and Ptc transcript levels were compared between male and female rat UGTs (Fig. 1F ). RPA analysis showed Shh and Ptc mRNA ex-pression was approximately 2.5-fold higher in females than males at e17.5, while at P0 and P6, transcript levels were similar between sexes. At P20, expression of Shh and Ptc transcripts was minimal in the male but still maintained in the female.
Shh and Ptc transcripts levels were analysed in VPs and URs grown in vitro with or without androgens. VPs were cultured for 6 days Ϫ/ϩ T (testosterone); or for 5 days with T followed by a 1 day treatment with the AR antagonist cyproterone acetate (CA) (Fig. 1G ). No significant difference in transcript abundance was noted for Shh or Ptc. Similarly, in short-term cultures of VPs (7 h or 3 days), no change in transcript levels was observed (data not shown). Analysis of transcript levels in the microdissected URs of female UGTs cultured for 3 days Ϫ/ϩ T revealed a 2.5-fold upregulation of Shh transcripts (Fig. 1H ), although no significant change in Ptc transcript levels was observed.
HH-signalling is not required for prostatic induction
UGTs were microdissected from e17.5 Shh null mice and examined; Shh null mice UGTs were smaller than those of their wild-type littermates (not shown), and the hindgut was contiguous with the bladder ( Fig. 2A ). As the prostate was not well developed in either mutant ( Fig. 2B ) or wildtype males at this stage, UGS explants from both Shh null mice and their littermates were grown in vitro to determine whether prostatic budding could be induced (n ϭ 3). Prostatic buds were present after 3 days and appeared enlarged after 5 days in both Shh null ( Fig. 2C ) and littermate UGS explants (not shown). Indian hedgehog (Ihh) is expressed in the VP at much lower levels than Shh by RT-PCR (data not shown), and it was possible that an upregulation of Ihh (or another Hh family member) may have compensated for lack of SHH in Shh null UGT explants. Therefore, e16.5 rat UGS explants were grown in vitro for 7 days Ϫ/ϩ T and Ϫ/ϩ 1, 5, or 10 M cyclopamine (Cy) (n ϭ 4), which blocks signalling via Smoothened and thus all Hh family ligands (Chen et al., 2002; Incardona et al., 1998) . Prostatic buds were not observed in explants grown ϪT (Fig. 2D ); prostatic buds were present in explants grown ϩT ( Fig. 2E ) and ϩT ϩ1 M Cy (Fig. 2F ) at similar levels. Prostatic buds were also present in explants grown ϩT ϩ5 M Cy and ϩT ϩ10 M Cy (data not shown), though these concentrations of Cy were toxic and caused premature organ death.
HH-signalling is involved in VP growth and branching
Next, the role of HH-signalling in prostate growth and branching morphogenesis was examined. P0 rat VPs were cultured for 6 days Ϫ/ϩT, and Ϫ/ϩCy (Fig. 3A) , and their 2D area was measured (n ϭ 21, 100 VPs from each of 4 treatment groups) (Fig. 3B ). The optimum concentration of Cy for growth inhibition was 1 M; 0.1 M Cy showed little or no effect and 10 M Cy appeared to be toxic. Disruption of HH-signalling significantly inhibited VP growth in the presence or absence of T. The addition of Cy to organs cultured ϪT resulted in a growth reduction of 16% (ϪT vs ϪT ϩCy; Student's t test, P ϭ 3.0e Ϫ14 ), and Cy reduced the growth of VPs cultured ϩT by 27% (ϩT vs ϩT ϩCy; Student's t test, P ϭ 1.4e Ϫ34 ).
The number of peripheral epithelial bud tips was counted in VPs cultured Ϫ/ϩT Ϫ/ϩCy (n ϭ 16, 60 VPs from each of 4 treatment groups) (Fig. 3C ). The addition of Cy to organs cultured ϪT caused a significant increase in the number of peripheral tips per unit perimeter (ϪT ϭ 60.16 ϩ/Ϫ 0.97 mean bud tips per unit perimeter/ϪT ϩCy ϭ 74.47 ϩ/Ϫ 1.07; Student's t test, P ϭ 1.31e Ϫ17 ), the increase in tip number observed ϪT ϩCy was similar to ϩT (ϩT ϭ 71.80 ϩ/Ϫ 0.83). VPs grown ϩT ϩCy showed fewer peripheral tips, when compared with those cultured ϩT (ϩT ϩCy ϭ 69.84 ϩ/Ϫ 1.13); however, this reduction showed a low statistical significance (Student's t test, P ϭ 0.08).
BrdU incorporation was used to calculate a proliferative index in VPs grown Ϫ/ϩT and Ϫ/ϩCy ( Fig. 3D ) (n ϭ 4, 9 organs in each treatment group). There was a significant reduction in stroma in VPs grown ϩTϩCy, which precluded accurate calculation of proliferative index of organs in this group. A proliferative index was calculated for the epithelium by colocalisation of BrdU with pan-Cytokeratin. The percentage of proliferating epithelial cells was scored from 3 images of the peripheral edges of the organs (distal), and 3 images of the ducts closest to the urethra (proximal), totalling 27 distal and proximal counts for each treatment group. A 30% reduction in proliferation was observed in the distal epithelial tips of organs cultured ϩCy, both Ϫ/ϩT (ϪT ϭ 18.92% ϩ/Ϫ 1.48% proliferative nuclei; ϪT ϩCy ϭ 13.48% ϩ/Ϫ 0.93%, Student's t test, P ϭ 0.002; ϩT ϭ 23.24% ϩ/Ϫ 1.86%; ϩT ϩCy ϭ 16.28% ϩ/Ϫ 0.74%, Student's t test, P ϭ 0.0005). No significant difference was observed in the percentage of proliferating cells in the ducts proximal to the UR in response to Cy.
Inhibition of SHH-signalling affects canalisation and differentiation of prostatic epithelial ducts
Prostatic ducts develop and grow as solid cords, which subsequently canalise. Canalisation occurs in a proximalto-distal direction (from the UR outwards), and may be the result of epithelial cell differentiation Wang et al., 2000) . After growth in vitro, lumens are present in the ducts proximal to the UR (Fig. 4G ), but not in the distal tips. Lumens were observed in the proximal ducts of VPs in all treatment groups, but VPs cultured ϩT ϩCy also exhibited lumens in almost all distal tips ( Fig. 4J-L) . The architecture of the peripheral ducts of VPs cultured ϩT ϩCy was not normal but had a cribiform appearance, with epithelial bridging suggesting multiple lumens and some expansion of the duct.
Undifferentiated prostatic epithelial cells at growing tips uniformly express cytokeratin 14 (CK14) and p63 (Parsons et al., 2001; Wang et al., 2000) . As epithelial cells differentiate, expression of CK14 and p63 becomes confined to the basal cell layer Parsons et al., 2001; Wang et al., 2000) . We investigated CK14 and p63 localisation in VPs grown in vitro Ϫ/ϩT and Ϫ/ϩCy. p63 expression was abundant in the epithelial cells of distal tips of organs cultured ϪT, ϪT ϩCy, and ϩT ( Fig. 4B, E, and H) . The majority of distal epithelial tips in these organs showed uniform p63 staining, characteristic of the undifferentiated state, while in others there was an increase in p63-positive cells towards the basement membrane. By contrast, in VPs cultured ϩT ϩCy, p63 expression was confined to the basal cell layer of all distal tips (Fig. 4K ). p63 expression was localised to the basal layer of epithelial cells in the proximal ducts of VPs from all treatment groups. Expression of CK14 showed similarities to p63, though less basal cells appeared CK14positive than p63-positive. The majority of distal tips in VPs cultured ϪT and ϪT ϩCy ( Fig. 4C and F) expressed CK14 broadly, in keeping with undifferentiated epithelial cells. Distal tips with both uniform expression of CK14 and with a defined layer of CK14-expressing basal cells were observed in VPs cultured ϩT (Fig. 4I ). VPs cultured ϩT ϩCy exhibited very few CK14-positive cells in distal tips (Fig.  4L) , contrasting with the relative abundance of p63-positive cells. CK14 expression was confined to the basal cell layer in the proximal ducts of VPs from all treatment groups.
Effect of exogenous SHH on VP growth and branching
The effects of adding recombinant SHH to VPs grown in vitro was examined ( Fig. 5 ). VPs were grown for 3 days Ϫ/ϩT and Ϫ/ϩ recombinant SHH protein (n ϭ 6). The addition of SHH to cultures resulted in expansion of the mesenchyme around the periphery of VPs, both Ϫ/ϩ T (Fig. 5A) . Measurement of the 2D area of the cultured VPs (n ϭ 6, 14 VPs from each treatment group) showed that the addition of SHH caused a small reduction in overall VP growth, both Ϫ/ϩ T, that showed a low statistical significance (ϪT vs. ϪT ϩSHH % area ϭ 100 ϩ/Ϫ 3.56 vs. 90.12 Ϫ/ϩ 5.26, Student's t test, P ϭ 0.07; ϩT vs. ϩT ϩSHH % area ϭ 127.05 ϩ/Ϫ 5.12 vs. 123.03 ϩ/Ϫ 6.75, Student's t test, P ϭ 0.32) (Fig. 5B) .
The number of peripheral bud tips from the cultured VPs was counted and expressed as a ratio to perimeter (Fig. 5C ). The addition of SHH to cultures significantly reduced the number of peripheral bud tips both Ϫ/ϩT, thus having an opposite effect to inhibiting HH-signalling with Cy (ϪT vs.
ϪT ϩSHH mean bud tips per 1000 pixels perimeter ϭ 68.65 ϩ/Ϫ 2.62 vs. 48.09 ϩ/Ϫ 3.35, Student's t test P ϭ The proliferative index of the epithelial and mesenchymal cell compartments was calculated for VPs cultured Ϫ/ϩT and Ϫ/ϩ SHH after the addition of BrdU (Fig. 5D ). Epithelial labelling index was calculated at day 3 of culture, while mesenchymal labelling index was calculated on day 2 of culture, since our data indicated that effects on mesenchymal proliferation were more pronounced on day 2 compared with day 3. In VPs grown ϪT, SHH reduced epithelial cell proliferation by a third ( 
Discussion
We have demonstrated that HH-signalling participates in growth of prostatic mesenchyme and epithelium, and in epithelial differentiation. Induction of prostatic budding, in response to T, in Shh null mouse UGS explants grown in vitro and in rat UGS explants cultured with Cy suggested that HH-signalling is not required for the induction of prostatic buds. However, inhibition of SHH-signalling during later stages of VP growth and branching retarded growth of VPs cultured in vitro, reduced epithelial proliferation, and increased the number of ductal tips in prostatic epithelia. In contrast, the addition of exogenous SHH to VPs grown in vitro reduced the number of ductal bud tips and caused mesenchymal expansion. In the presence of T, inhibition of SHH-signalling caused aberrant differentiation of prostatic epithelia that was reminiscent of PIN. We propose that SHH-signalling is not essential for prostatic induction, but is an important regulator of mesenchymal-epithelial interactions during later stages of prostate growth and development.
The temporal and spatial expression pattern of Shh in the P0 male rat UGT suggested a role for Shh in prostatic growth and development. Shh transcripts were localised to the epithelia of the urethra and developing prostatic lobes, in agreement with earlier studies of Shh transcript distribution (Bitgood and McMahon, 1995; Lamm et al., 2002; Podlasek et al., 1999) . Shh transcript distribution appeared uniform along the proximal-distal axis of the developing ducts, and in the UGS epithelium. This differed from the observations of Lamm et al., (2002) , who reported elevated levels of Shh transcripts in the tips of growing ducts, and diminished expression in the remainder of the UGS epithelium. We propose that these differences result from section artifact, as in some sections we only observed the tips of growing epithelial buds, which expressed Shh. RPA analysis showed Shh and Ptc transcripts to be most abundant at e18.5, correlating with the visible outgrowth of the urethral epithelium towards the ventral mesenchymal pad (VMP). Shh and Ptc transcript levels were elevated again at P0, associating with the surge of VP growth and branching that occurs in the neonatal period. The temporal expression pattern of Shh was in agreement with that of a recent study (Lamm et al., 2002) , and the ontogeny of Shh and Ptc expression in the male UGT was found to reflect that of Gli1 (Lamm et al., 2002) , a transcriptional mediator of SHH-signalling, and Bmp4, which is expressed in the mesenchyme surrounding the growing epithelial buds of the prostate (Lamm et al., 2001) . In the postnatal VP, high levels of Shh and Ptc transcripts were observed in the early neonatal period of growth and branching. These levels declined after P6 so that transcripts were almost undetectable by P20, when VP growth slows significantly until quiescence in adulthood. The temporal expression pattern of Shh and Ptc in the VP correlates with that of Fgf10, which, like Bmp4, is expressed in the mesenchyme surrounding growing epithelial buds (Thomson and Cunha, 1999) .
A comparison of Shh and Ptc transcript levels between the VP and UR of postnatal males revealed that, while transcript levels decreased in the VP approaching adulthood, expression in the UR was maintained at a similar level throughout development. These data suggest that SHHsignalling is required for growth and branching in the VP, and we propose that maintained SHH-signalling in the UR may be required for continued elongation of the UR into adulthood, or for the formation of urethral glands. Our data also suggest that high levels of Shh transcripts reported in the postnatal male mouse UGS (Podlasek et al., 1999) may have originated from the UR, and contrast with data suggesting that Shh transcripts are diminished in the UR relative to prostatic buds in neonates (Lamm et al., 2002) .
Comparisons of transcript levels between the male and female UGTs demonstrated that there was more Shh and Ptc mRNA in females than males, suggesting that direct androgen-regulation of these transcripts is unlikely. Our data were found to contradict that of Podlasek et al. (1999) , who reported 7-fold higher expression of Shh in male UGS than female UGS of e19 mice (Podlasek et al., 1999) . As we used RNase protection assays to quantify transcript levels, it is likely that our data are more accurate, though different microdissection techniques and species-specific differences cannot be ruled out. In support of these data, no significant difference in Shh and Ptc transcript levels was observed between VPs grown in vitro with or without T. Additionally, Podlasek et al. (1999) reported a 5-fold increase in Shh transcripts in e15 male mouse UGS explants cultured for 3 days with dihydrotestosterone. In agreement with this, we observed a 2.5-fold upregulation of Shh expression in response to T in the URs of female UGTs. Surprisingly, there was no upregulation of its receptor, Ptc, bringing into question the functional significance of this observation.
The emergence of prostatic buds in UGS explants from Shh null mice and rat UGS explants grown with Cy suggested that Shh (or Ihh or Dhh) is not critical for prostatic induction. Our results concur with experiments showing that when mouse UGS explants were cultured in the presence of 1 M Cy, prostatic budding was not inhibited (Lamm et al., 2002) . However, Lamm et al. (2002) reported inhibition of budding in UGS explants cultured with 5 and 10 M Cy; these concentrations of Cy caused extensive mesenchymal degeneration and early death of our UGS explants. We therefore propose that the presence of fewer prostatic buds at these concentrations of Cy was not due to direct inhibition of budding, but due to toxic effects of high Cy concentrations. This is supported by a recent study that showed 10 M Cy resulted in significant cell death in VP explant cultures (Wang et al., 2003) , though lower concentrations were non-toxic.
Nkx3.1 is the earliest known marker of prospective prostatic epithelium, and is expressed 2 days prior to the appearance of prostatic buds (Bhatia-Gaur et al., 1999) . Nkx3.1 is not required for prostatic induction, since Nkx3.1 null mutants still have a prostate (Bhatia-Gaur et al., 1999; Schneider et al., 2000) , but its expression is required for epithelial differentiation during development, and correct function of the prostate during adulthood (Bhatia-Gaur et al., 1999) . As Nkx3.1 is expressed in the male (but not the female) UGS, it is likely to be androgen-regulated, and as expression occurs before functional AR appears in the epithelium, this androgen-regulation is likely to be mediated via the mesenchyme (Bhatia-Gaur et al., 1999) . Previous studies have observed that Shh null mice do not express Nkx3.1 in the UGS (Schneider et al., 2000) , and current literature supports a hypothesis in which androgens upregulate Shh expression in males (Podlasek et al., 1999) and elicit a male-specific expression pattern (Lamm et al., 2002) , which in turn induces Nkx3.1 expression. However, our finding that Shh transcripts are found in the UGS of both males and females, and are not upregulated in males, and recent data showing that Nkx3.1 expression is found in Shh null explant cultures and tissue recombinants (D. Berman, X. Desai, C. Wang, C. Abate-Shen, P. Beachy, M.M., Shen, unpublished observations) suggest that Shh is not required for Nkx3.1 expression in the male UGS during prostatic induction. We also conclude from our data that Shh expression is not a prerequisite for prostatic induction.
A direct role for SHH was demonstrated in later stages of VP growth and development by inhibition and supplementation of the SHH-signalling pathway. Blocking SHH-signalling using both anti-SHH antibody (data not shown) and Cy resulted in a reduction in size of VPs and an increase in epithelial bud tip number. Growth effects resulting from antibody blockade confirmed that, during VP growth and development, signalling via SMO is dependent on SHH as a ligand. In contrast, the addition of rSHH to VPs grown in vitro had little effect on final organ size, but reduced epithelial bud tip number.
Both inhibiting SHH-signalling or adding rSHH to VPs grown in vitro affected prostatic mesenchyme. Although not directly quantified, there appeared to be a smaller proportion of mesenchyme in VPs cultured with Cy, which made calculation of a proliferative index not possible for this cell compartment. In VPs grown with recombinant SHH, a greater proportion of mesenchyme was apparent ( Fig. 5A) and an increase in proliferative rate was observed (Fig. 5D ). Thus, we propose that SHH-signalling is a regulator of prostatic mesenchymal cell proliferation. It appears that SHH is also a mitogen in kidney mesenchyme (Yu et al., 2002) , which suggests that SHH may function as regulator of mesenchymal proliferation in several urogenital tissues.
Counting the distal epithelial buds tips of the cultured VPs revealed that inhibiting SHH-signalling increased distal bud tip number and rSHH reduced distal bud tip number, with both treatments reducing epithelial mitogenesis. In mesenchyme-free lung explants, increased epithelial cell proliferation is not required for branching but is required for elongation (Nogawa et al., 1998) . We propose that inhibiting SHH-signalling increased bud tip number in cultured VPs by reducing mitogenesis and augmenting branching morphogenesis. This would suggest that in vivo SHH acts to inhibit branching and allow elongation of epithelial bud tips. We propose that the reduction in bud tip number in VPs cultured with rSHH was the result of branching inhibition. A significant increase in the number of ductal tips and branch points has also been observed in the VPs of Bmp4 haploinsufficient mice, and a decrease is observed when exogenous BMP4 is added to UGS explant cultures (Lamm et al., 2001) . Bmp4 is postulated to inhibit lateral branching, thereby allow elongation, of prostatic epithelial ducts (Lamm et al., 2001) . Shh and Bmp4 are expressed concurrently in adjacent epithelium and mesenchyme, respectively, at several sites during development (Bitgood and McMahon, 1995) , and it has been demonstrated that Shh can modulate the expression of Bmp4 (Haraguchi et al., 2001) . We suggest that Shh might operate upstream of Bmp4 in a pathway that inhibits branch formation in the prostate.
We observed that canalisation had occurred at the distal tips of VPs cultured ϩT ϩCy, whereas in VPs cultured ϪT, ϪT ϩCy, and ϩT, canalisation was only evident in proximal ducts. This suggested that in the presence of T inhibition of SHH-signalling accelerated canalisation, but that disruption of SHH-signalling alone was not sufficient to induce this effect. We propose that SHH-signalling inhibits canalisation of prostatic epithelial ducts in vivo, and so plays an opposing role to T, which promotes canalisation . The morphology of the distal tips of VPs cultured ϩT ϩCy was complex, with a well-developed cribiform pattern and multiple lumens. In human disease, this cribiform pattern can be seen in severe forms of benign epithelial hyperplasias and in high-grade PIN, the precursor of invasive carcinoma. In lesions of PIN, there is generally a single layer of basal cells, often with large gaps, and an expansion of the duct as in our VPs cultured ϩT ϩCy ( Fig.  4J-L) . These observations suggest that prostatic epithelia of our VPs, grown in vitro ϩT ϩCy, recapitulate some of the features of PIN.
There is a clear temporal and spatial relationship between canalisation of prostatic ducts and epithelial cell differentiation. Immunohistochemistry for the basal cell marker p63 revealed that the epithelia in all distal tips of VPs cultured ϩT ϩCy had differentiated. This suggested that inhibition of SHH-signalling in the presence of T accelerated epithelial cell differentiation. The expression pattern of another basal cell marker, CK14, was similar to that of p63, except that the majority of cells in the distal tips of VPs cultured ϩT ϩCy failed to express CK14. The absence of a complete layer of CK14-positive basal cells is well recognised in human prostate, where variations in expression of keratin subtypes are well described (Freeman et al., 2002) . The functional significance of these variations in keratin profile is unknown. Nevertheless, fewer CK-positive cells are generally seen in PIN than in normal glands (Bostwick and Brawer, 1987 ; P.H., personal observation), and the relative paucity of CK14-positive cells in VPs cultured ϩT ϩCy is again reminiscent of PIN.
Inappropriate activation of the SHH-signalling pathway has been implicated in several types of tumor (reviewed in Ruiz i Altaba et al., 2002) . Our data are novel in that inactivation of the SHH-signalling pathway during growth resulted in lesions suggestive of disease. The SHH-signalling pathway may control various genes implicated in prostatic disease, and Shh may be a factor involved in Nkx3.1 expression during postnatal prostatic epithelial growth or in prostatic disease. In addition to developmental defects, Nkx3.1 mutant mice develop lesions reminiscent of PIN (Bhatia-Gaur et al., 1999; Kim et al., 2002) , as in our ϩT ϩCy cultured VPs. Thus, it is possible that the PIN-like lesions observed in VPs grown ϩT ϩCy were due to a loss of Nkx3.1 expression. Further insight into our PIN-like lesions could be provided by characterising the effects of Cy on prostates in vivo, and investigating possible links between other genes implicated in PIN such as Nkx3.1 (Bhatia-Gaur et al., 1999) , Rxr␣ (Huang et al., 2002) , and Fgf8 (Song et al., 2002) that have been proposed to regulate or be regulated by Shh.
In conclusion, we have demonstrated that SHH-signalling is not critical for prostatic induction, but plays important roles in prostatic growth, branching morphogenesis, and epithelial differentiation. Inhibition of SHH-signalling during prostatic growth in vitro led to precocious and aberrant differentiation of epithelial cells, resulting in lesions akin to human cribiform PIN.
